Dina Jacobs, MD

Neurology
Accepting new patients
Sees patients age 18 and up
Penn Neuroscience Center - Neurology
View 1 additional location
Headshot of Dina Jacobs, MD
Penn Medicine Provider

About me

  • Clinical Director, Multiple Sclerosis and Related Disorders Center
  • Director of Community Outreach and Network Development, Multiple Sclerosis and Related Disorders Center
  • Professor of Neurology at the Hospital of the University of Pennsylvania

My education and training

  • Medical School: University of Pennsylvania School of Medicine
  • Residency: University of Pennsylvania Health System
  • Fellowship: University of Pennsylvania Health System

Spoken languages

English
English

Reviews

Average Rating

535 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
May 2026
knows her stuff!
Anonymous
May 2026
the care and compassion is exceptional.
Anonymous
May 2026
i like dr. jacobs. she is knowledgeable and personable that she makes you feel like a person besides just a patient
Anonymous
April 2026
dr is very honest and knowledgeable with medical answers. very personable.

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Jacobs is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Cooper EC, Bakhtiar N, Bar-Or A, Brandstadter RB, Gur RC, Horwath EA, Jacobs DA, Perrone CM, Roalf DR, Ruparel K, Satterthwaite TD, Shinohara RT, Schindler MK, Baller EB Penn Computerized Neurocognitive Battery Reveals Global and Task-Specific Deficits Across Multiple Cognitive Domains in Multiple Sclerosis , ACTRIMS Annual Meeting, San Diego, CA: 2026


Virupakshaia A, Gill AJ, Schoeps VA, Wilson EA, Wilson JA, Do D, Bar-Or A, Jacobs DA*, Berger JR*, *Co-Senior Authors The Effect of Ocrelizumab on Anti‐JC Virus Antibody Index , Brain and Behavior : 2026


Baldin E, De Santis C, Bove R, Jacobs D, McDonell J, Rijke N, Saylor D, Viswanathan S, Nonino F, and the KNOWwMS working group Knowledge Gaps in Reproductive Health among Women with MS: an international survey , European Academy of Neurology Congress, Geneva, Switzerland: 2026


Aggarwal A, Kavanaugh L, Santos I, Gilliard S, Wilson E, Giardino M, Jefferson A, Elahi A, Passarella M, Honeywell S, Gitelman Y, Lee K, Jacobs D A novel approach for operationalizing imaging import from external institutions , American Academy of Neurology Annual Meeting, Chicago, IL: 2026


Pfister A, Desai N, Lane C, Sweeney Smith M, Sekella N, Zimmerman V, Jacobs D Virtual Dance Program for Multiple Sclerosis: Feasibility, Quality of Life, and Motor Imagery Outcomes , International Journal of MS Care: 2025


Saylor D, Rijke N, McDonell J, Laurson-Doube J, Avasarala J, Baldin E, Banerjee TK, Bogdanovic I, Bove R, Chawla DK, Costello K, Del Giovane C, Abkari NE, Filippini G, Foschi M, Gonzalez-Lorenzo M, Helme A, Jacobs D, Kalincik T, Mantel-Teeuwisse A, Minozzi S, Navas C, Nonino F, Ojo OO, Ozcan B, Pasi E, Peryer G, Prato Chichiraldi A, Ridley B, Sokhi DS, Traboulsee A, Tramacere I, Tye JS, Vecchi S, Viswanathan S, Xie F, Zeineddine M, Schunemann H, Piggott T. Recommendations for essential medicines for multiple sclerosis in low-resource settings , Mult Scler: 2025


Hellwig K, Bove R, Oreja-Guevara C, Dobson R, Maillart E, Jacobs D, McElrath T, Derfuss TJ, Pietrasanta C, 9, Kletzl H, Kazlauskaite A, Zecevic D, 1 Raposo C, Lin C, Pasquarelli N, Vukusic S Infant B-Cell Levels, Ocrelizumab Placental Transfer and Maternal Humoral Responses During Pregnancy: Primary Analysis of the Prospective, Multicenter, Open-Label Phase IV MINORE Study , ACTRIMS Annual Meeting, West Palm Beach, FL: 2025


Bove R, Oreja-Guevara C, Vukusic S, Shah A, 4 Graham EL, McElrath T, Pietrasanta C, Dobson R, Maillart E, Jacobs D, Kletzl H, Kazlauskaite A, Zecevic D, Raposo C, Craveiro L, Lin C, Pasquarelli N, Hellwig K Placental and Breastmilk Transfer of Ocrelizumab from Women with Multiple Sclerosis to Infants and Potential Impact on B-Cell Levels in the Phase IV MINORE and SOPRANINO Trials , Consortium of MS Centers Annual Meeting, Phoenix, AZ: 2025


Sekella N, Gilmore H, French E, Zimmerman V, Jacobs D, Narula S. Developing and Piloting a Dedicated Support Group for Young Adults With Multiple Sclerosis , Int J MS Care: 2025


Cooper EC, Schindler MK, Bar-Or A, Brandstadter RB, Calkins ME, Gur R, Jacobs DA, Markowitz C, Moore T, Naydovich LR, Perrone CM, Ruparel K, Spangler BC, Troyan S, Shinohara RT, Satterthwaite TD, Baller EB. Investigating mood and cognition in people with multiple sclerosis: a prospective cross-sectional study protocol , BMJ Open: 2025